Mexclav 250 mg Tablet is a broad-spectrum antibiotic manufactured by Biopharma Laboratories Ltd., Bangladesh. It combines Cefuroxime Axetil (250 mg), a second-generation cephalosporin, with Clavulanic Acid (62.5 mg), a beta-lactamase inhibitor. This combination enhances the efficacy of Cefuroxime by protecting it from bacterial enzymes that would otherwise degrade it, thereby extending its antibacterial spectrum to include beta-lactamase-producing organisms.